Asia-Pacific Digital Respiratory Solutions Market to Grow by 41.6% Annually, Reaching $219 Million by 2030

Noble Horvath

DUBLIN, Sept. 4, 2020 /PRNewswire/ — The “Asia-Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering. The Asia-Pacific digital respiratory solutions market will grow by 41.6% annually with a total addressable […]

DUBLIN, Sept. 4, 2020 /PRNewswire/ — The “Asia-Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

The Asia-Pacific digital respiratory solutions market will grow by 41.6% annually with a total addressable market cap of $219 million over 2020-2030, owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic.

The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.

Highlighted with 31 tables and 42 figures, this 104-page report is based on a comprehensive research of the entire Asia-Pacific digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of Asia-Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia-Pacific digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Therapeutic Devices

Diagnostic Devices

  • Spirometers
  • Asthma Monitors
  • Other Diagnostic Devices

Sensors and Apps

Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • COVID-19 Caused Diseases
  • Other Diseases

Based on Distribution Channel, the Asia-Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Asia Pacific digital respiratory solutions market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players

  • 3M Health Care Limited
  • Adherium Limited
  • Amiko Digital Health Limited
  • AsthmaMD
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Capsule Technologies Inc.
  • Cohero Health
  • GlaxoSmithKline plc
  • Kaia Health Software GmbH
  • Medical International Research (MIR)
  • Novartis AG
  • NuvoAir
  • Reciprocal Labs (Propeller Health)
  • Sensiron AG
  • Tactio Health
  • Teva Pharmaceuticals Industries Ltd.

Key Topics Covered

1 Introduction
1.1 Industry Definition and Research Scope 
1.2 Research Methodology
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis

3 Segmentation of Asia Pacific Market by Product Type
3.1 Market Overview by Product Type
3.2 Therapeutic Devices
3.2.1 Inhalers
3.2.2 Nebulizers
3.3 Diagnostic Devices
3.3.1 Spirometers
3.3.2 Asthma Monitors
3.3.3 Other Diagnostic Devices
3.4 Sensors and Apps

4 Segmentation of Asia Pacific Market by Indication
4.1 Market Overview by Indication
4.2 Asthma
4.3 Chronic Obstructive Pulmonary Disease (COPD)
4.4 COVID-19 Caused Diseases
4.5 Other Diseases

5 Segmentation of Asia Pacific Market by Distribution Channel
5.1 Market Overview by Distribution Channel
5.2 Hospital Pharmacies
5.3 Retail Pharmacies
5.4 Online Pharmacies

6 Asia-Pacific Market 2019-2030 by Country
6.1 Overview of Asia-Pacific Market
6.2 Japan
6.3 China
6.4 Australia
6.5 India
6.6 South Korea
6.7 Rest of APAC Region

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles

  • 3M Health Care Limited
  • Adherium Limited
  • Amiko Digital Health Limited
  • AsthmaMD
  • AstraZeneca plc
  • Boehringer Ingelheim International GmbH
  • Capsule Technologies Inc.
  • Cohero Health
  • GlaxoSmithKline plc
  • Kaia Health Software GmbH
  • Medical International Research (MIR)
  • Novartis AG
  • NuvoAir
  • Reciprocal Labs (Propeller Health)
  • Sensiron AG
  • Tactio Health
  • Teva Pharmaceuticals Industries Ltd.

8 Investing in Asia Pacific Market: Risk Assessment and Management
8.1 Risk Evaluation of Asia Pacific Market
8.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/7ds260

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Next Post

Middle East and Africa Industrial Metal AM Printer Market With Industry Share, Growth, SWOT, Key Players and Forecast

The MarketWatch News Department was not involved in the creation of this content. Sep 03, 2020 (AmericaNewsHour) — Statistics According to GSMA, the Mobile Economy report, the adoption of smartphones is anticipated to rise from 52 percent in 2018 to 74 percent in 2025 in the Middle East and North […]